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Objective: Communicating the discontinuation of anticancer treatment to patients is a difﬁcult
task. The primary aim of this study was to clarify the level of oncologist-reported burden when
communicating about discontinuation of an anticancer treatment. The secondary aims were
(i) to identify the sources of burden contributing to their levels and (ii) to explore the useful
strategies to alleviate their burden.
Methods: A multicenter nationwide questionnaire survey was conducted on 620 oncologists
across Japan (response rate, 67%).
Results: High levels of perceived burden were reported by 47% of respondents, and 17%
reported that they sometimes, often or always wanted to stop oncology work because of this
burden. There was a signiﬁcant association between high levels of burden and: a feeling that
breaking bad news would deprive the patient of hope; concern that the patient’s family would
blame the oncologist; concern that the patient may lose self-control; and a feeling that there
was not enough time to break the bad news. Strategies perceived to be useful by oncologists
included training in how to effectively communicate to patients discontinuation of anticancer
treatment, a reduction in total workload to allow sufﬁcient time to break bad news, and devel-
opment of a multidisciplinary model to facilitate cooperation with other professionals and
facilities.
Conclusions: Many oncologists reported high levels of burden relating to communication of
discontinuation of anticancer treatment. A speciﬁc communication skills training program, suf-
ﬁcient time for communication and development of a multidisciplinary model could help allevi-
ate the burden on oncologists.
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INTRODUCTION
Breaking bad news is a stressful experience for the oncolo-
gist (1–6); moreover, it contributes to diminished conﬁdence
in communication skills and higher expectations of a
negative outcome. The experience of dealing with distressed,
angry and reproachful patients is also associated with
burnout (7). Previous studies have suggested that oncologist-
perceived burden is caused by several factors associated with
the patient, the patient’s family, the oncologists themselves
and the medical environment (8,9). An oncologist’s com-
munication style affects the extent of emotional distress felt
by the patient and the patient’s family (10). The most
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ation of curative treatment and admission to a hospice (4);
therefore, it is important to clarify the extent of the burden
experienced by the oncologist when communicating the dis-
continuation of anticancer treatment.
Many studies have been conducted to clarify patients’ pre-
ferences and experiences in receiving bad news in oncology
settings (11–14), and several clinical guidelines and expert
recommendations have been published (1,15,16). Moreover,
recent intervention trials have demonstrated that structured
communication skills training can improve physicians’ skills
in breaking bad news (17–19).
Despite the existence of many experience-based rec-
ommendations and studies into the psychological effects on
patients and their families, to our knowledge, only a few
studies have explored the extent of the burden on oncologists
when communicating the discontinuation of anticancer treat-
ment. Therefore, the aims of the present study were to: (i)
clarify the level of oncologist-perceived burden when com-
municating the discontinuation of anticancer treatment to
patients; (ii) identify factors contributing to this burden; and
(iii) explore potentially useful strategies to alleviate
oncologist-perceived burden.
PATIENTS AND METHODS
SUBJECTS
The present study was a cross-sectional anonymous multi-
center nationwide survey of oncologists in cancer centers
across Japan. Questionnaires were mailed to 620 eligible
oncologists in February 2007 and again 2 months later to
those oncologists who had not yet responded. If the oncol-
ogists did not want to participate in the survey, we
requested that they return the questionnaire without reply-
ing to any of the questions. The participating institutions
were 12 cancer centers selected from the 15 cancer centers
that make up the Japanese Association of Clinical Cancer
Centers.
We recognized potential sampling bias with this method,
but decided to use convenient institutions because we felt
that the risk of sampling bias would be minimized by a large
number of participants.
Eligibility criteria for the participants were as follows: (i)
oncologists specializing in gastroenterology, respiratory
medicine, breast oncology, hematology, medical oncology,
urology, gynecology, otolaryngology, orthopedics, pediatrics,
neurosurgery or dermatology; and (ii) the oncologist’s name
had to appear on his/her medical facility’s website. The
website of all Japanese cancer centers shows the complete
list of all physicians in that center. We regarded the com-
pletion and return of the questionnaire as consent to partici-
pate in the study. The institutional review board of the
principal investigator conﬁrmed the study’s ethical and
scientiﬁc validity.
QUESTIONNAIRE
A questionnaire was developed based on a review of the lit-
erature (2,3,8,9) and discussions among the authors. Content
validity was assessed by full agreement of the authors, and
face validity was conﬁrmed by a pilot test of 20 potential
participants.
As background data, oncologists reported their age,
gender, clinical experience in oncology, specialty, previous
experience with formal communication skills training, atti-
tudes toward disease and prognosis disclosure for terminally
ill patients, and the number of patients to whom they would
usually communicate the discontinuation of anticancer treat-
ment annually.
The primary endpoint was oncologist-perceived burden
imposed by communicating the discontinuation of anticancer
treatment to patients. Given the lack of existing validated
instruments, the following outcome parameters were devel-
oped by the authors. First, the level of oncologist-perceived
burden was evaluated by the question, ‘What level of burden
do you feel when you communicate with patients about dis-
continuation of anticancer treatment?’ Answers to this ques-
tion were rated on a ﬁve-point scale ranging from 1 (I do not
feel any burden at all) to 5 (I feel a heavy burden). In
addition, we investigated the impact of the burden on motiv-
ation to continue working in oncology by asking oncologists,
‘How often do you feel some level of desire to stop oncol-
ogy work due to this burden’. Again, answers were rated on
a ﬁve-point scale ranging from 1 (not at all) to 5 (always).
We extracted 20 potential sources of burden from the lit-
erature (8,9) and questioned oncologists on their level of per-
ceived burden relating to each of these sources. Oncologists
were requested to rate their degree of burden on a ﬁve-point
Likert-type scale ranging from 1 (I do not feel any burden)
to 5 (I feel a heavy burden).
In addition, we developed a list of 14 potentially useful
strategies to alleviate oncologists’ perceived burden derived
from a previous report (20) and from a qualitative study
using in-depth interviews with three oncologists. The oncol-
ogists were requested to rate their level of agreement with
each of these strategies on a six-point Likert-type scale
ranging from 1 (not necessary) to 6 (absolutely necessary).
STATISTICAL ANALYSES
For comparisons, respondents were classiﬁed into two
groups: oncologists who rated themselves as ‘heavily bur-
dened’ or ‘burdened’ (high-level burden) and then all other
oncologists (low-level burden). This cut-off point was
selected on the basis of the actual distribution of the data
and enabled the entire sample to be divided into two equal-
sized groups for comparison.
To explore the determinants of levels of oncologist-
reported burden, we screened 7 background variables and 20
sources of burden. Univariate analyses were performed using
Student’s t-test or the x
2 test, as appropriate. To assess the
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cal signiﬁcance was deﬁned as 0.0025 (0.05/20) using the
Bonferroni correction. Multiple logistic regression analyses
were then performed using a forward elimination procedure.
All potential predictors with statistical signiﬁcance as ascer-
tained by the univariate analyses were included as indepen-
dent variables in multiple logistic regression analyses. All
analyses were performed using SPSS version 11.0.
RESULTS
Of the 620 questionnaires mailed to oncologists, 10 were
undeliverable because of incorrect addresses and 416 oncolo-
gists returned questionnaires, resulting in a response rate of
67%. Of the questionnaires returned, 3 were excluded due to
missing data in primary endpoints and 19 were returned
without any of the questions being answered. Thus, a total of
394 responses were analyzed, giving an effective response
rate of 67% (394/591). The oncologists’ characteristics are
summarized in Table 1.
Overall levels of oncologist-reported burden relating to
communication of the discontinuation of anticancer treat-
ment were: heavily burdened, 13%; burdened, 34%; slightly
burdened, 37%; not particularly burdened, 13%; or not bur-
dened at all, 1.3% (Table 2). Clinical oncologists rated their
level of desire to stop oncology work because of this burden
as: not at all, 55% (n ¼ 218); rarely, 26% (n ¼ 106); some-
times, 11% (n ¼ 45); often, 5.3% (n ¼ 21); or always, 1.0%
(n ¼ 4).
The oncologists’ ratings of the 20 potential sources
of burden relating to the communication of discontinuation
of anticancer treatment are given in Table 3.M o r et h a n2 0 %
of respondents reported feeling ‘heavily burdened’ or ‘bur-
dened’ by the following factors: insufﬁcient time to break
bad news; feeling that breaking bad news will deprive the
patient of hope; the possibility that the breaking of bad news
is interrupted by other tasks; concern that the patient may
lose self-control; opposition from the patient’s family to
breaking bad news to the patient; the fact that evidence from
a certain group is not applicable to every patient; and,
ﬁnally, an inability to answer philosophical questions regard-
ing death and the value of life.
Univariate analysis (Table 4) showed that oncologists with
high-level burden were signiﬁcantly more likely to report the
following concerns: feeling that breaking bad news will
deprive the patient of hope; concern that the oncologist may
be blamed by the patient’s family; concern that the patient
may lose self-control; insufﬁcient time to break bad news;
possibility that the time for breaking bad news is interrupted
by other tasks; opposition from the patient’s family to break-
ing bad news to the patient; evidence from a certain group is
not applicable to every patient; an inability to answer philo-
sophical questions regarding death and the value of life;
feeling a sense of guilt because oncologists cannot provide
adequate treatment; concern that the oncologist may be
criticized by the patient; scientiﬁc evidence is not always
predictable or reproducible; opposition from patients to
breaking bad news to their families; fear of talking to
patients whom the oncologist do not know very well; lack of
conﬁdence in oncological medical skills; uneasiness in chan-
ging roles from curing patients to caring for patients; and a
concern that an objective stance cannot be maintained if the
oncologist becomes too intimate with the patient.
Multiple logistic regression analysis (Table 4) revealed
that independent determinants of high-level burden were:
feeling that breaking bad news will deprive the patient of
hope; concern that the oncologist may be blamed by the
patient’s family; concern that the patient may lose self-
control; and insufﬁcient time to break bad news. Seven back-
grounds of the oncologist, including age, specialty, attitudes
toward disease and prognosis disclosure for terminally ill
patients, oncology experience, previous experience with
Table 1. Background of respondent oncologists
Age (years)
Median 43
Inter-quartile range 37–50
Male gender [no. (%)] 371 (91)
Oncology experience (years)
Median 15
Inter-quartile range 8–20
Number of communications concerning discontinuation of anticancer
treatment annually
Median 8
Inter-quartile range 3–15
Attitudes toward disease and prognosis disclosure for terminally ill patients
a
[no. (%)]
Routinely, without patient’s request 55 (14)
If necessary, without patient’s request 234 (59)
If necessary, and if the patient explicitly asks 78 (19)
Routinely, and if the patient explicitly asks 21 (5.3)
Specialty
a [no. (%)]
Gastroenterology 116 (30)
Respiratory medicine 50 (13)
Breast oncology 42 (10)
Hematology, medical oncology 42 (10)
Urology 32 (8.3)
Gynecology 30 (7.8)
Otolaryngology 24 (6.2)
Orthopedics 19 (4.9)
Neurosurgery 12 (3.1)
Pediatrics 13 (3.3)
Dermatology 5 (1.3)
Received formal training in breaking bad news [no. (%)] 59 (16.5)
aPercentages do not add up to 100% because of missing data.
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munications concerning discontinuation of anticancer treat-
ment annually, are not the determinants of levels of
oncologist-reported burden.
Strategies to relieve oncologist-reported burden when
communicating the discontinuation of anticancer treatment
were also investigated. Table 5 lists the percentage of
oncologists who agreed with each of the 14 strategies
suggested to alleviate oncologists’ perceived burden. More
than 20% of respondents considered the following strategies
to alleviate oncologist-reported burden as ‘absolutely necess-
ary’: that an inpatient hospice is readily available and that
patient information is exchanged smoothly among facilities;
quiet and private rooms are available for breaking bad news;
after breaking bad news, a nurse, psychologist or medical
social worker is available to provide emotional support; and
a reduction in oncologists’ total workload to give them sufﬁ-
cient time to break bad news.
DISCUSSION
To the best of our knowledge, this is the ﬁrst large multicenter
nationwide survey to investigate oncologist-reported burden
when communicating the discontinuation of anticancer treat-
ment. The ﬁrst important ﬁnding of the present study was the
demonstration of the oncologist-reported burden when
Table 3. Sources of oncologist-reported burden when communicating discontinuation of anticancer treatment
‘Not
burdened at
all’, no. (%)
‘Not particularly
burdened’, no.
(%)
‘Slightly
burdened’,
no. (%)
‘Burdened’,
no. (%)
‘Heavily
burdened’,
no. (%)
Insufﬁcient time to break bad news 12 (3.1) 61 (15) 90 (22) 151 (36) 82 (20)
Feeling that breaking bad news will deprive the patient of hope 12 (3.1) 34 (8.7) 152 (37) 135 (33) 63 (15)
Possibility that the time for breaking bad news is interrupted by other tasks 18 (4.6) 86 (21) 102 (25) 120 (29) 71 (17)
Concern that the patient may lose self-control 16 (4.1) 83 (21) 163 (39) 108 (26) 25 (6.0)
Opposition from family members to breaking bad news to the patient 39 (9.9) 96 (24) 134 (32) 91 (22) 36 (8.7)
Evidence from a certain group does not always apply to the patient 43 (10) 122 (31) 133 (32) 70 (17) 28 (6.7)
The oncologist is unable to answer philosophical questions regarding death and the
value of life
37 (9.5) 122 (31) 140 (34) 74 (18) 21 (5.0)
Concern that the oncologist may be blamed by the patient’s family 73 (18) 141 (35) 104 (25) 63 (15) 15 (3.6)
Feeling a sense of guilt because oncologists cannot provide effective anticancer
treatment
83 (21) 140 (35) 102 (25) 56 (14) 14 (3.4)
Opposition from patients to breaking bad news to their families 70 (17) 171 (43) 87 (21) 47 (11) 19 (4.6)
Concern that the oncologist may be criticized by the patient 75 (19) 149 (37) 107 (26) 56 (14) 9 (2.2)
Fear of talking to patients whom oncologist does not know very well 84 (21) 138 (35) 108 (26) 54 (13) 10 (2.4)
Scientiﬁc evidence is not always predictable or reproducible 43 (10) 122 (31) 133 (32) 70 (17) 28 (6.7)
Lack of conﬁdence in oncological medical skills 63 (16) 172 (43) 106 (26) 49 (12) 5 (1.2)
Concern that the oncologist does not have the latest knowledge 80 (20) 179 (45) 97 (23) 36 (8.7) 2 (0.5)
Uneasiness in changing roles from curing patients to caring for patients 111 (28) 176 (44) 68 (16) 34 (8.2) 4 (1.0)
Concern that oncologists cannot answer all knowledge-based questions posed by the
patient
94 (24) 186 (47) 81 (20) 29 (7.0) 3 (0.7)
Oncologists fear their own illness and death 122 (31) 178 (45) 62 (15) 26 (6.3) 4 (1.0)
Concern that an objective stance cannot be maintained if the oncologist becomes too
intimate with the patient
89 (22) 195 (49) 85 (20) 24 (5.8) 3 (0.7)
Fear that oncologists themselves may become very emotionally involved, such as
expressing anger or sadness
107 (27) 209 (53) 59 (14) 18 (4.3) 0 (0)
Percentages do not add up to 100% due to missing data.
Table 2. Levels of oncologist-reported burden when communicating
discontinuation of anticancer treatment
No. (%)
Heavily burdened 53 (13)
Burdened 136 (34)
Slightly burdened 147 (37)
Not particularly burdened 53 (13)
Not burdened at all 5 (1.3)
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patients. Of the oncologists surveyed, 47% reported high
levels of burden when communicating the discontinuation of
anticancer treatment. Moreover, 17% of the oncologists sur-
veyed reported that they sometimes, often or always want to
stop oncology work because of this burden. Multiple studies
have revealed that a major contributor to physicians’ burnout
is communication with patients and families (21–26). The
present study conﬁrms that communication with patients and
families is a major source of oncologists’ work-related stress.
In particular, the present study highlights that communicating
the discontinuation of anticancer treatment can be a heavy
burden for oncologists and that it is urgent that strategies are
developed to alleviate this burden.
The present study also evaluated oncologists’ opinions
regarding the strategies likely to be effective in reducing this
burden. The strategies perceived to be potentially effective
included: ready availability of an inpatient hospice and
smooth exchange of patient information among facilities;
availability of quiet and private rooms for the breaking of
bad news; the provision of emotional support from a nurse,
psychologist or medical social worker after the patient has
received the bad news; and a reduction in oncologists’ total
workload to give them sufﬁcient time to break the bad news.
Moreover, multiple logistic regression analyses revealed
that independent determinants of high-level burden were: a
feeling that breaking bad news will deprive the patient of
hope; concern that the oncologist may be blamed by the
patient’s family; concern that the patient may lose self-
control; and insufﬁcient time to break bad news.
These results reveal that there are three main areas that, if
addressed, could signiﬁcantly alleviate oncologist-reported
burden: (i) improving oncologists’ communication skills; (ii)
allowing sufﬁcient time for communication with patients and
Table 4. Determinants of oncologist-reported burden when communicating discontinuation of anticancer treatment
Univariate analyses Multivariate analyses
Low level
(n ¼ 206)
High level
(n ¼ 190)
P value Odds ratio
(95% CI)
P value
Feeling that breaking bad news will deprive the patient of hope 3.1+0.9 3.8+0.8 ,0.01 1.8 (1.4–2.5) ,0.01
Concern that the oncologist may be blamed by the patient’s family 2.1+0.8 2.8+1.1 ,0.01 1.5 (1.2–1.9) ,0.01
Concern that the patient may lose self-control 2.8+0.8 3.4+0.9 ,0.01 1.4 (1.1–1.9) ,0.01
Insufﬁcient time to break bad news 3.3+1.0 3.8+0.9 ,0.01 1.2 (0.99–1.6) 0.049
Possibility that the time for breaking bad news is interrupted by other tasks 3.1+1.0 3.5+1.1 ,0.01
Opposition from family members to breaking bad news to the patient 2.7+1.0 3.2+1.1 ,0.01
Evidence from a certain group does not always apply to every patient 2.6+0.9 3.0+1.1 ,0.01
The oncologist is unable to answer philosophical questions regarding death and the value of
life
2.5+0.8 3.0+1.0 ,0.01
Feeling a sense of guilt because oncologists cannot provide effective anticancer treatment 2.1+0.9 2.7+1.1 ,0.01
Concern that the oncologist may be criticized by the patient 2.1+0.8 2.7+1.0 ,0.01
Scientiﬁc evidence is not always predictable or reproducible 2.3+0.8 2.7+1.0 ,0.01
Opposition from patients to breaking bad news to their families 2.2+0.8 2.6+1.2 ,0.01
Fear of talking to patients whom the oncologist does not know very well 2.2+0.9 2.5+1.1 ,0.01
Lack of conﬁdence in oncological skills 2.2+0.8 2.5+0.9 ,0.01
Uneasiness in changing roles from curing patients to caring for patients 1.9+0.8 2.3+0.9 ,0.01
Concern that an objective stance cannot be maintained if the oncologist becomes too
intimate with the patient
1.9+0.7 2.2+0.8 ,0.01
Concern that the oncologist does not have the latest knowledge 2.1+0.8 2.2+0.9 0.24
Fear that the oncologist may become very emotionally involved, such as expressing anger or
sadness
1.9+0.6 2.0+0.8 0.24
Concern that the oncologist cannot answer all knowledge-based questions posed by the
patient
2.0+0.8 2.2+0.9 0.34
Fear of the oncologists’ own illness and death 1.9+0.7 2.0+1.0 0.78
Oncologists who rated their burden level as heavily burdened or burdened (high-level group) are compared as a single group against all others (low-level
group). Multiple logistic regression analyses used the high-level burden group as the dependent variable. Each condition was rated on a scale of 1 (do not feel
any burdened) to 5 (feel heavily burdened).
Jpn J Clin Oncol 2011;41(8) 1003their families; and (iii) developing a multidisciplinary care
model with other professionals and facilities.
This study emphasizes the importance of communication
skills. Previous studies suggested that communication skills
training increases both patient satisfaction (27,28)a n do n c o l -
ogists’ conﬁdence (29). However, to the best of our knowl-
edge, existing communication skills training does not
speciﬁcally address issues surrounding the discontinuation of
anticancer treatments. The present study highlights the impor-
tance, under these difﬁcult circumstances, of helping the
patient maintain hope, dealing with the oncologists’ fear of
being blamed by the patients and their families, and strength-
ening patient self-control. The results indicate that a com-
munication skills training program speciﬁcally targeting skills
for communicating the discontinuation of anticancer treat-
ment needs to be developed. This program should include
strategies to deal with oncologists’ concerns, such as that by
breaking bad news to a patient, the oncologist will deprive the
patient of hope, that the oncologist may be blamed by the
patient’s family and that the patient may lose self-control.
The oncologists surveyed stressed the importance of a
reduction in their total workload to give them sufﬁcient time
to facilitate effective communication with patients. A pre-
vious study suggested that physicians face excessive work-
loads that are associated with a lower quality of patient care
(30). Several studies have suggested that the perception of
having insufﬁcient time to communicate with patients is the
factor most strongly associated with oncologist burnout
(22,31) .I nJ a p a n ,a c c o r d i n gt oa2 0 0 8r e v i s i o nb yt h e
Ministry of Health, Labor and Welfare in Japan of the
payment of fees for medical treatment, an additional fee for
outpatient care can be applied when a physician is directly
involved in clinical practice for 5 min or longer. This indi-
cates that the Ministry of Health, Labor and Welfare in
Japan deﬁnes the time for consultation and implies that most
physicians in Japan are too busy to spend 5 min or more on
each outpatient. These results stress that a reduction in phys-
icians’ workload is vital.
Many oncologists surveyed in the present study agreed with
the importance of multidisciplinary cooperation with other
professionals and facilities. Two types of cooperation were
considered to be particularly valuable: (i) that after breaking
bad news, a nurse, psychologist or medical social worker was
available to follow up with patients and their families; and (ii)
the availability of other facilities, especially inpatient pallia-
tive care units. Previous studies have shown that cancer
patients’ participation in nurse-led interventions resulted in an
improvement in depressive moods (32,33). Multiple interven-
tion studies have indicated that practice-based interprofes-
sional collaboration can improve patients’ health-care
processes and outcomes (34). Furthermore, existing literature
indicates that regional palliative care programs succeed in
increasing family satisfaction (35,36). These ﬁndings suggest
that developing a multidisciplinary team to support oncolo-
gists, not only within a hospital, but also beyond the hospital
(as a region), is of considerable importance in achieving
patient and family satisfaction. As the number of palliative
care units in Japan is not enough, increasing the reimburse-
ment for inpatient hospice would be important as policy.
Moreover, because oncologist burden was not measured in
these previous studies, prospective observational or interven-
tional studies are needed to determine whether a team
Table 5. Oncologists’ opinion on strategies suggested to alleviate the burden associated with communicating discontinuation of anticancer treatment
Necessary
(%)
Absolutely
necessary (%)
Inpatient hospice is readily available and patient information is exchanged smoothly among facilities 49 36
Quiet and private rooms are available for breaking bad news 56 25
After breaking bad news, a nurse, psychologist or medical social worker is available for emotional support 63 24
A reduction in the oncologist’s total workload to give sufﬁcient time for the breaking of bad news 54 23
While breaking bad news, a nurse, psychologist or medical social worker is available for emotional support 56 13
Having an opportunity to attend educational workshops about how to break bad news 51 6.8
A psychiatrist or psychologist is available for consultation if the oncologist feels overburdened 42 6.6
Before breaking bad news, having the opportunity to discuss the situation with colleagues and receive advice 54 6.1
After breaking bad news, specialists in physician–patient communication are available to give advice to the oncologist about
how they should break bad news
60 5.5
Having opportunities to share experiences and feelings with the colleagues within the hospital 51 5.5
Before breaking bad news, information about what the patient and family want to know is available from nurses 65 5.0
Before breaking bad news, the oncologist receives a memo from the patient and family about what they want to know 61 3.8
After breaking bad news, the oncologist receives a questionnaire to identify what the patient and the family are feeling and
thinking
65 3.3
Have an opportunity to share experiences and feelings with colleagues from other hospitals 47 3.0
1004 Burden on oncologistsapproach, such as in-hospital and regional palliative care pro-
grams, could alleviate oncologist burden.
The limitations of the present study include the moderate
(67%) effective response rate, which may mean that the
entire oncological population is not represented by the oncol-
ogists who participated in the present study. Furthermore,
because this study was performed in Japan, the results are
likely to be inﬂuenced by factors relating to Japanese culture
and the Japanese health-care system and, as such, may not
be applicable to other countries.
In conclusion, a considerable number of oncologists experi-
enced high levels of burden in communicating the decision to
discontinue anticancer treatment. To alleviate oncologist
burden, potentially useful strategies include: (i) communi-
cation skills training speciﬁcally targeting discontinuation of
anticancer treatment; (ii) a reduction in total workload to
allow oncologists sufﬁcient time to break bad news; and (iii)
the development of a multidisciplinary model to facilitate
cooperation with other professionals and facilities.
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